Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals: The Hoorn Study

This publication has 29 references indexed in Scilit:

• Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study
  The Lancet, 2002
• Plasma S -adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine
  The American Journal of Clinical Nutrition, 2001
• Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease
  Atherosclerosis, 2001
• Pathways and Regulation of Homocysteine Metabolism in Mammals
  Seminars in Thrombosis and Hemostasis, 2000
• Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes
  Circulation, 2000
• Homocysteine and Hypomethylation: A Novel Link to Vascular Disease
  Published by Elsevier ,1999
• Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
  Diabetes Care, 1999
• Homocysteine and Atherothrombosis
  New England Journal of Medicine, 1998
• Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
  Kidney International, 1995